The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Living After a Rare Cancer of the Ovary: Chronic Fatigue, Quality of Life and Late Effects of Chemotherapy
Official Title: Living After a Rare Cancer of the Ovary: Chronic Fatigue, Quality of Life and Late Effects of Chemotherapy
Study ID: NCT03418844
Brief Summary: While they are documented in patients in remission of testicular cancer, the sequelae of chemotherapy and the impact of the disease and its treatments on the living conditions and QoL of women in remission of rare ovarian cancer remain poorly explored. The coordinator therefore propose a national 2-step case-control study to evaluate 1) chronic fatigue and QoL and 2) chemotherapy-related sequelae in adult patients in remission of surgery-treated TGMO or TSCS (conservative or not) supplemented with chemotherapy
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: Yes
Centre Paul Papin, Angers, , France
CHU Besançon Jean MINJOZ, Besançon, , France
Institut Bergonié, Bordeaux, , France
CH Fleyriat, Bourg-en-Bresse, , France
Centre François Baclesse, Caen, , France
Centre Jean Perrin, Clermont-Ferrand, , France
Centre Léon Berard, Lyon, , France
Institut Paoli Calmettes, Marseille, , France
Centre Catherine de Sienne, Nantes, , France
Institut de Cancérologie de l'Ouest, Nantes, , France
GH Cochin Broca Hôtel-Dieu, Paris, , France
HEGP, Paris, , France
Hôpital Diaconesses-Croix St Simon, Paris, , France
Institut Curie,, Paris, , France
Institut Gustave Roussy, Paris, , France
CHU Poitiers, Poitiers, , France
Institut Jean Godinot, Reims, , France
Institut Rennais de Cancérologie, Rennes, , France
CHRU Stasbourg Hôpital Civil, Strasbourg, , France
Name: Florence JOLY
Affiliation: Centre François Baclesse
Role: PRINCIPAL_INVESTIGATOR